Showing results (41-50 of 136) with videos related to

Sort By:
Pageof 14
Cancer Medicine|December 10, 2015
Intravenous high-dose interferon with or without maintenance treatment in melanoma at high risk of recurrence: meta-analysis of three trialsAgnieszka Malczewski, Andrea Marshall, Miranda J Payne, et al.
European Radiology|January 16, 2019
Routinely staging gastric cancer with <sup>18</sup>F-FDG PET-CT detects additional metastases and predicts early recurrence and death after surgeryJohn M Findlay, Stefan Antonowicz, Ashvina Segaran, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 4, 2018
VCAM-1-targeted MRI Enables Detection of Brain Micrometastases from Different Primary TumorsVinton W T Cheng, Manuel Sarmiento Soto, Alexandre A Khrapitchev, et al.
British Journal of Cancer|July 24, 2018
25-hydroxyvitamin D serum levels in patients with high risk resected melanoma treated in an adjuvant bevacizumab trialAstrid Lipplaa, Ricardo Fernandes, Andrea Marshall, et al.
Cancer Medicine|April 28, 2016
Real-world treatment practice in patients with advanced melanoma in the era before ipilimumab: results from the IMAGE studyMark R Middleton, Stéphane Dalle, Joel Claveau, et al.
European Journal of Cancer (Oxford, England : 1990)|December 28, 2014
PACMEL: a phase 1 dose escalation trial of trametinib (GSK1120212) in combination with paclitaxelNicholas Coupe, Pippa Corrie, Mirela Hategan, et al.
European Journal of Cancer (Oxford, England : 1990)|October 19, 2021
Indirect treatment comparison of nivolumab versus placebo as adjuvant treatment for resected melanomaJeffrey S Weber, Paolo A Ascierto, Mark R Middleton, et al.
The Lancet. Oncology|June 6, 2013
Selumetinib plus dacarbazine versus placebo plus dacarbazine as first-line treatment for BRAF-mutant metastatic melanoma: a phase 2 double-blind randomised studyCaroline Robert, Reinhard Dummer, Ralf Gutzmer, et al.
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS|May 27, 2011
Sentinel lymph node biopsy in melanoma: The Oxford ten year clinical experienceMilap G Rughani, Marc C Swan, Titus S Adams, et al.
International Journal of Cancer|August 29, 2013
XPF protein levels determine sensitivity of malignant melanoma cells to oxaliplatin chemotherapy: suitability as a biomarker for patient selectionStephanie B Hatch, Lonnie P Swift, Simona Caporali, et al.
Pageof 14